Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Aldeyra Therapeutics, Inc. (ALDX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
9 Aug 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
11,350,085
+1%
115,000
$7.55
$867,750.00
BUY
8 Aug 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
11,235,085
+0%
97,000
$7.24
$702,280.00
BUY
4 Aug 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
10,997,085
+0%
95,100
$6.17
$586,767.00
BUY
2 Aug 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
10,801,985
+3%
412,406
$5.59
$2,305,349.50
BUY
1 Aug 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
10,389,579
+1%
144,185
$5.05
$728,134.25
BUY
23 Jun 2022
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
1,216,535
+1%
17,700
$3.36
$59,546.34
BUY
23 Jun 2022
JOYCE MARTIN JOSEPH
Director
Aldeyra Therapeutics, Inc.
(ALDX)
23,967
+22%
4,323
$3.48
$15,024.59
BUY
3 May 2021
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
9,903,879
+13%
1,200,000
$12.50
$15,000,000.00
BUY
19 Jan 2021
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
8,703,879
+18%
1,368,421
$9.50
$13,000,000.00
BUY
7 Jan 2021
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
7,132,790
+17%
1,050,000
$8.76
$9,202,668.00
BUY
9 Jul 2020
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
6,285,458
+103%
3,200,000
$4.25
$13,600,000.00
BUY
16 Mar 2020
DOUGLAS RICHARD
Director
Aldeyra Therapeutics, Inc.
(ALDX)
125,000
+47%
40,000
$2.75
$110,000.00
BUY
16 Dec 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
652,216
+3%
20,000
$5.10
$101,908.00
BUY
30 Sep 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
632,216
+1%
8,710
$5.68
$49,483.25
BUY
23 Sep 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
623,506
+1%
8,680
$5.81
$50,432.54
BUY
18 Sep 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
614,826
+2%
14,288
$5.91
$84,464.95
BUY
17 Sep 2019
Bronstein Ben
Director
Aldeyra Therapeutics, Inc.
(ALDX)
18,644
+10%
1,700
$5.85
$9,945.00
BUY
13 Sep 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
591,991
+2%
13,000
$5.85
$75,990.00
BUY
13 Sep 2019
DOUGLAS RICHARD
Director
Aldeyra Therapeutics, Inc.
(ALDX)
85,000
+6%
5,000
$6.00
$30,000.00
BUY
12 Sep 2019
JOYCE MARTIN JOSEPH
Director
Aldeyra Therapeutics, Inc.
(ALDX)
19,644
+9%
1,700
$5.86
$9,964.21
BUY
11 Sep 2019
DOUGLAS RICHARD
Director
Aldeyra Therapeutics, Inc.
(ALDX)
80,000
+33%
20,000
$5.89
$117,805.00
BUY
9 Sep 2019
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
578,991
+3%
20,000
$5.14
$102,824.00
BUY
9 Sep 2019
DOUGLAS RICHARD
Director
Aldeyra Therapeutics, Inc.
(ALDX)
60,000
+50%
20,000
$5.00
$99,963.00
BUY
6 Sep 2019
Clark David J
Chief Medical Officer, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
17,878
+38%
5,000
$5.06
$25,311.00
BUY
5 Sep 2019
McMullin David
Chief Commerical Officer, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
6,148
+237%
4,329
$4.68
$20,259.72
BUY
5 Sep 2019
Reed Joshua
Chief Financial Officer, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
35,774
+9%
3,200
$4.71
$15,072.00
SELL
26 Mar 2019
TREU JESSE I
Director
Aldeyra Therapeutics, Inc.
(ALDX)
1,877,091
-4%
96,743
$10.01
$968,397.44
BUY
19 Sep 2017
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
3,085,458
+6%
200,000
$7.25
$1,450,000.00
BUY
30 Jun 2017
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
2,885,458
+11%
296,007
$4.60
$1,361,632.10
BUY
17 Feb 2017
Brady Todd C
President and CEO, Director, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
64,408
+52%
22,223
$4.50
$100,003.50
BUY
17 Feb 2017
DOUGLAS RICHARD
Director
Aldeyra Therapeutics, Inc.
(ALDX)
40,000
+100%
40,000
$4.50
$180,000.00
BUY
17 Feb 2017
Tulipano Stephen J
Chief Financial Officer, Officer
Aldeyra Therapeutics, Inc.
(ALDX)
3,333
+100%
3,333
$4.50
$14,998.50
BUY
17 Feb 2017
JOYCE MARTIN JOSEPH
Director
Aldeyra Therapeutics, Inc.
(ALDX)
17,944
+32%
4,444
$4.50
$19,998.00
BUY
17 Feb 2017
Bronstein Ben
Director
Aldeyra Therapeutics, Inc.
(ALDX)
16,944
+35%
4,444
$4.50
$19,998.00
BUY
14 Feb 2017
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
2,589,451
+52%
893,025
$4.50
$4,018,612.50
BUY
26 May 2016
PERCEPTIVE ADVISORS LLC
10% Owner
Aldeyra Therapeutics, Inc.
(ALDX)
1,940,458
+56%
700,000
$5.00
$3,500,000.00
Home